NIH Director Francis Collins wants people – the general public – to know that there are some seriously "creative minds" working to find innovative ways to use genomic information to assess disease risk and treat patients.

He took to his Director's Blog this week to highlight the research of two NIH-supported investigators who are at the forefront of applying genomic variants in understanding disease risk.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Mining Data Mountains

Hoping for More

This Week in PNAS

This Week in Nature

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.